The Valley Desk

NCT07703462 · Interventional trial

Personalized Antisense Oligonucleotide Therapy for a Participant With TARDBP ALS

Overall registry status Enrolling by invitation

Phase 1 · Phase 2

Conditions Amyotrophic Lateral Sclerosis (ALS)

Delaware Valley sites

First posted

Registry updated

Added to the directory

View this study on ClinicalTrials.gov